AdvisorShares Pure US Cannabis ETF
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company.
AI analysis
An AI analyst reads AdvisorShares Pure US Cannabis ETF's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about AdvisorShares Pure US Cannabis ETF
Is AdvisorShares Pure US Cannabis ETF a good stock to buy?
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the AdvisorShares Pure US Cannabis ETF AI analysis
What does AdvisorShares Pure US Cannabis ETF do?
The First U.S.-Listed ETF Available – MSOS is the first actively managed U.S.-listed ETF with dedicated cannabis exposure focusing exclusively on U.S. companies, including multi-state operators. It is in Asset Management.
How has AdvisorShares Pure US Cannabis ETF stock done over the past year?
Down 12.4% over the past twelve months, to $4.10. It traded between $2.99 and $6.69 and is 38.7% below its high.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.